Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2024Información Comercial Española, ICE: Revista de economía

Serum Growth Differentiation Factor 15 Levels Predict the Incidence of Frailty among Patients with Cardiometabolic Diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

KOKazuhito ObaJIJoji IshikawaYTYoshiaki Tamura

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Oba et al. (2024) studied this question.

synapsesocial.com/papers/69dcc8cba5c75be4cfe54599https://doi.org/10.1159/000536150
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders2015 · 283 citations
  2. 2Validity of the <scp>K</scp>ihon Checklist for assessing frailty status2015 · 716 citations
  3. 3Inflammation and frailty in the elderly: A systematic review and meta-analysis2016 · 1,111 citations
  4. 4Association between frailty and ischemic heart disease: a systematic review and meta-analysis2021 · 71 citations
  5. 5Serum growth differentiation factor 15 level is associated with muscle strength and lower extremity function in older patients with cardiometabolic disease2020 · 48 citations